{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,20]],"date-time":"2026-06-20T04:08:17Z","timestamp":1781928497446,"version":"3.54.5"},"reference-count":48,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2013,6,1]],"date-time":"2013-06-01T00:00:00Z","timestamp":1370044800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,6,1]],"date-time":"2013-06-01T00:00:00Z","timestamp":1370044800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001700","name":"Ministry of Education, Culture, Sports, Science and Technology","doi-asserted-by":"publisher","award":["22591953"],"award-info":[{"award-number":["22591953"]}],"id":[{"id":"10.13039\/501100001700","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001700","name":"Ministry of Education, Culture, Sports, Science and Technology","doi-asserted-by":"publisher","award":["S1101027"],"award-info":[{"award-number":["S1101027"]}],"id":[{"id":"10.13039\/501100001700","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical Pharmacology"],"published-print":{"date-parts":[[2013,6]]},"DOI":"10.1016\/j.bcp.2013.04.006","type":"journal-article","created":{"date-parts":[[2013,4,17]],"date-time":"2013-04-17T13:56:35Z","timestamp":1366206995000},"page":"1770-1782","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":21,"title":["Infliximab counteracts tumor necrosis factor-\u03b1-enhanced induction of matrix metalloproteinases that degrade claudin and occludin in non-pigmented ciliary epithelium"],"prefix":"10.1016","volume":"85","author":[{"given":"Hiroshi","family":"Yamada","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masahiko","family":"Yoneda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shingo","family":"Inaguma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daisuke","family":"Watanabe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shogo","family":"Banno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuhiro","family":"Yoshikawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keigo","family":"Mizutani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masayoshi","family":"Iwaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masahiro","family":"Zako","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bcp.2013.04.006_bib0005","first-page":"1544","article-title":"Overproduction of monocyte-derived TNF-\u03b1, IL-6, IL-8 and increased neutrophil superoxide generation in Beh\u00e7et's disease. A comparative study with familial Mediterranean fever and healthy subjects","volume":"20","author":"Mege","year":"1993","journal-title":"J Rheumatol"},{"key":"10.1016\/j.bcp.2013.04.006_bib0010","first-page":"128","article-title":"Systemic levels of the T cell regulatory cytokines IL-10 and IL-12 in Beh\u00e7et's disease; soluble TNFR-75 as a biological marker of disease activity","volume":"24","author":"Turan","year":"1997","journal-title":"J Rheumatol"},{"key":"10.1016\/j.bcp.2013.04.006_bib0015","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1080\/09629350220131935","article-title":"Serum levels of TNF-alpha, sIL-2R, IL-6, and IL-8 are increased and associated with elevated lipid peroxidation in patients with Beh\u00e7et's disease","volume":"11","author":"Evereklioglu","year":"2002","journal-title":"Mediators Inflamm"},{"key":"10.1016\/j.bcp.2013.04.006_bib0020","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1111\/j.1365-2230.2004.01684.x","article-title":"Serum interleukin 18 and tumour necrosis factor-alpha levels are increased in Behcet's disease","volume":"30","author":"Oztas","year":"2005","journal-title":"Clin Exp Dermatol"},{"key":"10.1016\/j.bcp.2013.04.006_bib0025","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1177\/112067210901900616","article-title":"Inflammatory mediators and posterior segment involvement in ocular Behcet disease","volume":"19","author":"Ozdamar","year":"2009","journal-title":"Eur J Ophthalmol"},{"key":"10.1016\/j.bcp.2013.04.006_bib0030","series-title":"Adler's physiology of the eye","first-page":"274","article-title":"Production and flow of aqueous humor","author":"Gabelt","year":"2011"},{"key":"10.1016\/j.bcp.2013.04.006_bib0035","series-title":"Adler's physiology of the eye","first-page":"243","article-title":"Ocular circulation","author":"Riva","year":"2011"},{"key":"10.1016\/j.bcp.2013.04.006_bib0040","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1089\/jop.2010.0079","article-title":"Effect of infliximab on tumor necrosis factor-alpha-induced alterations in retinal microvascular endothelial cells and retinal pigmented epithelial cells","volume":"26","author":"Li","year":"2010","journal-title":"J Ocul Pharmacol Ther"},{"key":"10.1016\/j.bcp.2013.04.006_bib0045","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/S0140-6736(01)05497-6","article-title":"Effect of infliximab on sight-threatening panuveitis in Beh\u00e7et's disease","volume":"358","author":"Sfikakis","year":"2001","journal-title":"Lancet"},{"key":"10.1016\/j.bcp.2013.04.006_bib0050","first-page":"1362","article-title":"Efficacy, safety, and pharmacokinetics of multiple administration of infliximab in Beh\u00e7et's disease with refractory uveoretinitis","volume":"31","author":"Ohno","year":"2004","journal-title":"J Rheumatol"},{"key":"10.1016\/j.bcp.2013.04.006_bib0055","doi-asserted-by":"crossref","first-page":"2478","DOI":"10.1002\/art.21231","article-title":"Efficacy of infliximab in the treatment of uveitis that is resistant to treatment with the combination of azathioprine, cyclosporine, and corticosteroids in Beh\u00e7et's disease: an open-label trial","volume":"52","author":"Tugal-Tutkun","year":"2005","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.bcp.2013.04.006_bib0060","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1136\/bjo.2003.037192","article-title":"Anti-TNF-alpha therapy for sight threatening uveitis","volume":"89","author":"Lindstedt","year":"2005","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.bcp.2013.04.006_bib0065","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1007\/s00296-008-0606-8","article-title":"Safety and efficacy of infliximab therapy in active Behcet's uveitis: an open-label trial","volume":"29","author":"Al-Rayes","year":"2008","journal-title":"Rheumatol Int"},{"key":"10.1016\/j.bcp.2013.04.006_bib0070","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1016\/j.ajo.2008.09.010","article-title":"Infliximab effects compared to conventional therapy in the management of retinal vasculitis in Beh\u00e7et disease","volume":"146","author":"Tabbara","year":"2008","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.bcp.2013.04.006_bib0075","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1159\/000329091","article-title":"Cataract surgery in Beh\u00e7et's disease patients one week after infliximab administration","volume":"2","author":"Handa","year":"2011","journal-title":"Case Rep Ophthalmol"},{"key":"10.1016\/j.bcp.2013.04.006_bib0080","first-page":"S58","article-title":"Long-term remission of ocular and extraocular manifestations in Beh\u00e7et's disease using infliximab","volume":"29","author":"Handa","year":"2011","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.bcp.2013.04.006_bib0085","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1159\/000338703","article-title":"Trabeculotomy in a Beh\u00e7et's disease patient one week after infliximab administration","volume":"3","author":"Koike","year":"2012","journal-title":"Case Rep Ophthalmol"},{"key":"10.1016\/j.bcp.2013.04.006_bib0090","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1167\/iovs.02-0559","article-title":"Effects of cloricromene, a coumarin derivative, on endotoxin-induced uveitis in Lewis rats","volume":"44","author":"Bucolo","year":"2003","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.bcp.2013.04.006_bib0095","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1001\/archophthalmol.2009.141","article-title":"Infliximab therapy for refractory uveitis: 2-year results of a prospective trial","volume":"127","author":"Suhler","year":"2009","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.bcp.2013.04.006_bib0100","doi-asserted-by":"crossref","first-page":"6930","DOI":"10.1038\/onc.2008.344","article-title":"Tight junction-based epithelial microenvironment and cell proliferation","volume":"27","author":"Tsukita","year":"2008","journal-title":"Oncogene"},{"key":"10.1016\/j.bcp.2013.04.006_bib0105","doi-asserted-by":"crossref","first-page":"161","DOI":"10.3109\/10520290903504340","article-title":"Comparison of tight junction protein expression in the ciliary epithelia of mouse, rabbit, cat and human eyes","volume":"86","author":"Karim","year":"2011","journal-title":"Biotech Histochem"},{"key":"10.1016\/j.bcp.2013.04.006_bib0110","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1002\/dvdy.20142","article-title":"Expression patterns of claudin family of tight junction membrane proteins in developing mouse submandibular gland","volume":"231","author":"Hashizume","year":"2004","journal-title":"Dev Dyn"},{"key":"10.1016\/j.bcp.2013.04.006_bib0115","doi-asserted-by":"crossref","first-page":"2007","DOI":"10.1016\/S0161-6420(96)30393-X","article-title":"Acquired neoplasms of the nonpigmented ciliary epithelium (adenoma and adenocarcinoma)","volume":"103","author":"Shields","year":"1996","journal-title":"Ophthalmology"},{"key":"10.1016\/j.bcp.2013.04.006_bib0120","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1136\/jcp.2004.017871","article-title":"Ciliary body adenoma of non-pigmented epithelium","volume":"57","author":"Mansoor","year":"2004","journal-title":"J Clin Pathol"},{"key":"10.1016\/j.bcp.2013.04.006_bib0125","series-title":"Adler's physiology of the eye","first-page":"243","article-title":"Ocular circulation","author":"Riva","year":"2011"},{"key":"10.1016\/j.bcp.2013.04.006_bib0130","first-page":"3541","article-title":"MMPs and proteinase inhibitors in the human aqueous humor","volume":"34","author":"Ando","year":"1993","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.bcp.2013.04.006_bib0135","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1097\/01.ijg.0000212229.57922.72","article-title":"Levels and activation of matrix metalloproteinases in aqueous humor are elevated in uveitis-related secondary glaucoma","volume":"15","author":"M\u00e4\u00e4tt\u00e4","year":"2006","journal-title":"J Glaucoma"},{"key":"10.1016\/j.bcp.2013.04.006_bib0140","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.3109\/02713689609017656","article-title":"Increased matrix metalloproteinases in the aqueous humor of patients and experimental animals with uveitis","volume":"15","author":"Di Girolamo","year":"1996","journal-title":"Curr Eye Res"},{"key":"10.1016\/j.bcp.2013.04.006_bib0145","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1076\/0271-3683(200003)2031-9FT211","article-title":"Correlation of metalloproteinase-2 and -9 with proinflammatory cytokines interleukin-1b, interleukin-12 and the interleukin-1 receptor antagonist in patients with chronic uveitis","volume":"20","author":"El-Shabrawi","year":"2000","journal-title":"Curr Eye Res"},{"key":"10.1016\/j.bcp.2013.04.006_bib0150","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1002\/lsm.20931","article-title":"Increase in matrix metalloproteinase-2 level in the chicken retina after laser photocoagulation","volume":"42","author":"Takeyama","year":"2010","journal-title":"Lasers Surg Med"},{"key":"10.1016\/j.bcp.2013.04.006_bib0155","doi-asserted-by":"crossref","first-page":"3485","DOI":"10.1167\/iovs.02-0756","article-title":"Expression of matrix metalloproteinases and their inhibitors in human trabecular meshwork cells","volume":"44","author":"Pang","year":"2003","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.bcp.2013.04.006_bib0160","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1016\/j.exer.2008.11.023","article-title":"Extracellular matrix turnover and outflow resistance","volume":"88","author":"Keller","year":"2009","journal-title":"Exp Eye Res"},{"key":"10.1016\/j.bcp.2013.04.006_bib0165","doi-asserted-by":"crossref","first-page":"2377","DOI":"10.1016\/j.ophtha.2012.05.032","article-title":"Risk of hypotony in noninfectious uveitis","volume":"119","author":"Daniel","year":"2012","journal-title":"Ophthalmology"},{"key":"10.1016\/j.bcp.2013.04.006_bib0170","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.semarthrit.2010.09.002","article-title":"Anti-TNF agents for Beh\u00e7et's disease: analysis of published data on 369 patients","volume":"41","author":"Arida","year":"2011","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.bcp.2013.04.006_bib0175","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/1472-6793-12-2","article-title":"Matrix metalloproteinases 2 and 9 increase permeability of sheep pleura in vitro","volume":"12","author":"Apostolidou","year":"2012","journal-title":"BMC Physiol"},{"key":"10.1016\/j.bcp.2013.04.006_bib0180","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1136\/gut.51.4.507","article-title":"Effect of stress on the paracellular barrier in the rat ileum","volume":"51","author":"Mazzon","year":"2002","journal-title":"Gut"},{"key":"10.1016\/j.bcp.2013.04.006_bib0185","doi-asserted-by":"crossref","first-page":"1805","DOI":"10.1128\/AAC.50.5.1805-1812.2006","article-title":"Novel effects of azithromycin on tight junction proteins in human airway epithelia","volume":"50","author":"Asgrimsson","year":"2006","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.bcp.2013.04.006_bib0190","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1186\/1742-2094-9-161","article-title":"Epigallocatechin gallate inhibits endotoxin-induced expression of inflammatory cytokines in human cerebral microvascular endothelial cells","volume":"9","author":"Li","year":"2012","journal-title":"J Neuroinflammation"},{"key":"10.1016\/j.bcp.2013.04.006_bib0195","doi-asserted-by":"crossref","first-page":"3044","DOI":"10.1523\/JNEUROSCI.6409-11.2012","article-title":"Matrix metalloproteinase-2-mediated occludin degradation and caveolin-1-mediated claudin-5 redistribution contribute to blood\u2013brain barrier damage in early ischemic stroke stage","volume":"32","author":"Liu","year":"2012","journal-title":"J Neurosci"},{"key":"10.1016\/j.bcp.2013.04.006_bib0200","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1007\/s00417-011-1912-5","article-title":"Methylglyoxal induces hyperpermeability of the blood\u2013retinal barrier via the loss of tight junction proteins and the activation of matrix metalloproteinases","volume":"250","author":"Kim","year":"2012","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"10.1016\/j.bcp.2013.04.006_bib0205","doi-asserted-by":"crossref","first-page":"e20599","DOI":"10.1371\/journal.pone.0020599","article-title":"Matrix metalloproteinase-2 and -9 secreted by leukemic cells increase the permeability of blood\u2013brain barrier by disrupting tight junction proteins","volume":"6","author":"Feng","year":"2011","journal-title":"PLoS ONE"},{"key":"10.1016\/j.bcp.2013.04.006_bib0210","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.brainres.2011.07.013","article-title":"Methamphetamine transiently increases the blood\u2013brain barrier permeability in the hippocampus: role of tight junction proteins and matrix metalloproteinase-9","volume":"1411","author":"Martins","year":"2011","journal-title":"Brain Res"},{"key":"10.1016\/j.bcp.2013.04.006_bib0215","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1007\/978-1-61779-185-7_24","article-title":"MMP-mediated disruption of claudin-5 in the blood\u2013brain barrier of rat brain after cerebral ischemia","volume":"762","author":"Yang","year":"2011","journal-title":"Methods Mol Biol"},{"key":"10.1016\/j.bcp.2013.04.006_bib0220","doi-asserted-by":"crossref","first-page":"2022","DOI":"10.1007\/s11064-011-0526-y","article-title":"Effect of baicalin on matrix metalloproteinase-9 expression and blood\u2013brain barrier permeability following focal cerebral ischemia in rats","volume":"36","author":"Tu","year":"2011","journal-title":"Neurochem Res"},{"key":"10.1016\/j.bcp.2013.04.006_bib0225","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1111\/j.1365-2990.2010.01157.x","article-title":"Role of matrix metalloproteinase-9 (MMP-9) in striatal blood\u2013brain barrier disruption in a 3-nitropropionic acid model of Huntington's disease","volume":"37","author":"Duran-Vilaregut","year":"2011","journal-title":"Neuropathol Appl Neurobiol"},{"key":"10.1016\/j.bcp.2013.04.006_bib0230","doi-asserted-by":"crossref","first-page":"92","DOI":"10.3171\/2010.6.JNS10207","article-title":"The role of hypoxia-inducible factor-1\u03b1, aquaporin-4, and matrix metalloproteinase-9 in blood\u2013brain barrier disruption and brain edema after traumatic brain injury","volume":"114","author":"Higashida","year":"2011","journal-title":"J Neurosurg"},{"key":"10.1016\/j.bcp.2013.04.006_bib0235","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.brainres.2011.11.052","article-title":"HIV-1 Tat protein increases the permeability of brain endothelial cells by both inhibiting occludin expression and cleaving occludin via matrix metalloproteinase-9","volume":"1436","author":"Xu","year":"2012","journal-title":"Brain Res"},{"key":"10.1016\/j.bcp.2013.04.006_bib0240","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1111\/j.1471-4159.2011.07542.x","article-title":"Caveolin-1 regulates nitric oxide-mediated matrix metalloproteinases activity and blood\u2013brain barrier permeability in focal cerebral ischemia and reperfusion injury","volume":"120","author":"Gu","year":"2012","journal-title":"J Neurochem"}],"container-title":["Biochemical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S000629521300230X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S000629521300230X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,2]],"date-time":"2025-11-02T15:02:04Z","timestamp":1762095724000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S000629521300230X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,6]]},"references-count":48,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2013,6]]}},"alternative-id":["S000629521300230X"],"URL":"https:\/\/doi.org\/10.1016\/j.bcp.2013.04.006","relation":{},"ISSN":["0006-2952"],"issn-type":[{"value":"0006-2952","type":"print"}],"subject":[],"published":{"date-parts":[[2013,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Infliximab counteracts tumor necrosis factor-\u03b1-enhanced induction of matrix metalloproteinases that degrade claudin and occludin in non-pigmented ciliary epithelium","name":"articletitle","label":"Article Title"},{"value":"Biochemical Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bcp.2013.04.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}